Tag: intrasaccular device
Arissa Medical enrols first patients in first-in-human Syntra study
Arissa Medical has announced the enrolment of the first patients in its Syntra study—a first-in-human (FIH), early feasibility study evaluating the safety and efficacy...
Arissa Medical announces positive feasibility study results with Syntra intrasaccular scaffold
Arissa Medical has announced the successful evaluation of the Syntra intrasaccular scaffold system within simulated use conditions under fluoroscopy using clinically relevant, in-vitro intracranial...
“The third way” in intrasaccular aneurysm treatment demonstrates positive one-year outcomes
A device labelled “the third way” to potentially treat intracranial aneurysms via an intrasaccular approach has demonstrated positive effectiveness and safety results at one...
Nautilus represents “next evolution” of intrasaccular systems in aneurysm care
The Nautilus system (Endostream Medical)—a self-conforming intrasaccular flow diverter intended for the treatment of intracranial aneurysms—heralds the “next evolution” in these types of neurovascular...
Continued improvement of flow diverters and intrasacculars holds key to truly...
Laurent Pierot’s (Reims University Hospitals, Reims, France) long career in the treatment of intracranial aneurysms predates not only what many consider to be the...
Microvention announces five-year WEB-IT data alongside two new device sizes
Microvention, a wholly owned subsidiary of Terumo Corporation, has announced the publication of five-year follow-up data from the WEB-IT trial and the addition of two...
WEB 17 device maintains efficacy, safety across ruptured and unruptured aneurysms
The Woven EndoBridge (WEB) 17 device (Microvention/Terumo Corporation) has demonstrated positive efficacy and safety outcomes in the prospective, multicentre CLEVER study, indicating its utility...
